社会兼职： 中华医学会消化分会胃肠功能性疾病协作组副组长 中华便秘医学会学术部委员会副会长 广东省健康管理学会胰腺疾病专业委员会副主委 中华消化心身联盟广东省委员会首届常务理事 发表通信和第一作者SCl论著: 1. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study bycluster sampling. Alimentary Pharmacology & Therapeutics 2004; 19:1217-24. (-)2. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: A population-based study in SouthChina. Scandinavian Journal of Gastroenterology 2005; 40:759-67. ( #-) 3. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophagealreflux. Journal of Gastroenterology and Hepatology 2008; 23:290-5. (-)4. Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinalsymptoms. Journal of Digestive Diseases 2010; 11:83-7. (-)5. Cognitive-behavioral therapy for irritable bowel syndrome: A meta-analysis. Journal of Psychosomatic Research 2014;77:1-12.(通信) 6. Control of Foxo1 Gene Expression by Co-activator P300. Journal of Biological Chemistry 2014; 289:4326-33. ()7. The spectra, symptom profiles and overlap of Rome Il functional gastrointestinal disorders in a tertiary center in SouthChina. Journal of Digestive Diseases 2014; 15:538-44. (-) 8. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumaticdiseases: A prospective randomized study. Digestive and Liver Disease 2015; 47:280-4. (-) 9. Increased smallintestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients withdiarrhoea-predominant iritable bowel syndrome. Digestive and Liver Disease 2016; 48:880-7. (通信) 10. Natural history of adult onset Menetrier's disease: Report of a case with 9-year follow-up. Experimental and Therapeutic Medicine 2016; 11:2462-6. (通信) 11. Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional boweldisorders. Journal of Gastroenterology and Hepatology 2017; 32:1450-6. (-)12. Prevalence of lactose intolerance in patients with diarrhea -predominant irritable bowel syndrome: data from a tertiarycenter in southern China. Journal of Health Population and Nutrition 2017; 36. (-)13. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis. Journal ofGastroenterology and Hepatology 2017; 32:28-38. (通信)14. Fecal Microbiota Alterations Associated With Diarrhea-Predominant Iritable Bowel Syndrome. Frontiers in Microbiology2018;9.(通信) 15. Peroxisome Elevation Induces Stem Cell Differentiation and Intestinal Epithelial Repair. Developmental Cell 2020; 53: 169- 184.e11.(共一) 16. The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant iritablebowel syndrome. Bmc Gastroenterology 2020; 20. (通信) 17. Short- course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. Bmc Gastroenterology 2020; 20. (通信 ) 18. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.Bmc Gastroenterology 2021; 21. (通信) 19. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2021; 11.(通信) 20. Golden bifid might improve diarhea-predominant iritable bowel syndrome via microbiota modulation. Journal of HealthPopulation and Nutrition 2022; 41. (通信) 21. Gastrointestinal bleeding caused by metastatic testicular choriocarcinoma: a case report and literature review. WorldJournal of Surgical Oncology 2022; 20. (通信) 22. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome. Journal of Gastroenterology andHepatology 2023;38:1072-82.(通信) 23. Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and SerumMetabolites. Nutrients 2023; 15. (通信) 24. Efficacy and safety of Bifidobacterium quadruple viable tablets combined with mosapride citrate in the treatment ofconstipation in China: a systematic review and meta-analysis. Bmc Gastroenterology 2023; 23. (通信)25. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Reviewand Network Meta-Analysis. Nutrients 2023; 15. (通信) 26. Multiomics Analysis Reveals Gut Virome- Bacteria-Metabolite Interactions and Their Associations with Symptoms inPatients with IBS-D. Viruses 2024 Jun 29;16(7):1054. (通信) 27. Diagnostic accuracy of a simplified tool for irritable bowel syndrome with predominant constipation in Chinese patients:A multicenter, prospective, observational study. Chin Med J (Eng). 2024 Oct 20; 137(20): 2509-11. (通信)28. Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota andMetabolism. J Gastroenterol Hepatol. 2025 Jun; 40(6): 1561-1573. ( 通信 ) 29. Werner syndrome exonuclease promotes gut regeneration and causes age -associated gut hyperplasia in Drosophila.PLoS Biol.2025 Apr 22;23(4):e3003121.(共-) 其他工作成绩： 1）获抗击非典三等功及广州抗击非典先进个人； 2）《胃食管反流病的系列研究》获2013 年广州市科学技术奖励科技进步类 一等奖； 3）主持国家自然科学基金、广东省科技计划、广东省自然科学基金、中山大学青年教师基金及广东省医学科研基金等各类科研项目； 4）作为核心专家，执笔书写2013年《中国慢性便秘诊治指南》、2015年《中国肠易激综合征专家共识意见》）、《2019年中国慢性便秘共识意见》、《2020年中国肠易激综合征专家共识意见》、2024年《双歧杆菌四联活菌片在消化系疾病临床应用的专家共识》、2024年《消化不良中国家庭合理用药专家建议（科普实践版）》及《功能性便秘中西医结合诊疗专家共识（2025年）》等全国共识意见。